Evidence map›Paper›PMID 19859528›Full record

ArticlePLoS biology2009

Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation.

Nils Paulmann, Maik Grohmann, Jörg-Peter Voigt, Bettina Bert, Jakob Vowinckel, Michael Bader, Masa Skelin, Marko Jevsek, Heidrun Fink, Marjan Rupnik and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 190 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed, 1 pooled it
20.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 1 synthesis or guideline pooled it, 381 citations in OpenAlex.

  1. Pooled it
  2. GDM-associated insulin deficiency hinders the dissociation of SERT from ERp44 and down-regulates placental 5-HT uptake.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Special Issue "Serotonin in Health and Diseases".International journal of molecular sciences · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. The gut feeling in motion sickness.Communications biology · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Nils PaulmannDepartment of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Maik Grohmann
Jörg-Peter Voigt
Bettina Bert
Jakob Vowinckel
Michael Bader
Masa Skelin
Marko Jevsek
Heidrun Fink
Marjan Rupnik
Diego J Walther
Freie Universität Berlin · DEMax Planck Institute for Molecular Genetics · DEUniversity of Maribor · SIMax Delbrück Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While serotonin (5-HT) co-localization with insulin in granules of pancreatic beta-cells was demonstrated more than three decades ago, its physiological role in the etiology of diabetes is still unclear. We combined biochemical and electrophysiological analyses of mice selectively deficient in peripheral tryptophan hydroxylase (Tph1-/-) and 5-HT to show that intracellular 5-HT regulates insulin secretion. We found that these mice are diabetic and have an impaired insulin secretion due to the lack of 5-HT in the pancreas. The pharmacological restoration of peripheral 5-HT levels rescued the impaired insulin secretion in vivo. These findings were further evidenced by patch clamp experiments with isolated Tph1-/- beta-cells, which clearly showed that the secretory defect is downstream of Ca(2+)-signaling and can be rescued by direct intracellular application of 5-HT via the clamp pipette. In elucidating the underlying mechanism further, we demonstrate the covalent coupling of 5-HT by transglutaminases during insulin exocytosis to two key players in insulin secretion, the small GTPases Rab3a and Rab27a. This renders them constitutively active in a receptor-independent signaling mechanism we have recently termed serotonylation. Concordantly, an inhibition of such activating serotonylation in beta-cells abates insulin secretion. We also observed inactivation of serotonylated Rab3a by enhanced proteasomal degradation, which is in line with the inactivation of other serotonylated GTPases. Our results demonstrate that 5-HT regulates insulin secretion by serotonylation of GTPases within pancreatic beta-cells and suggest that intracellular 5-HT functions in various microenvironments via this mechanism in concert with the known receptor-mediated signaling.

Indexed as

Protein Processing, Post-TranslationalAnimalsCell LineDiabetes MellitusHumansInsulinInsulin-Secreting CellsInsulin SecretionIntracellular SpaceMicePatch-Clamp Techniquesrab27 GTP-Binding Proteinsrab3A GTP-Binding Proteinrab GTP-Binding ProteinsRatsSerotoninInsulinRab27a protein, mouserab27 GTP-Binding Proteinsrab3A GTP-Binding Proteinrab GTP-Binding ProteinsSerotoninTransglutaminasesTryptophan Hydroxylase

Identifiers

PMID19859528
PMCPMC2760755
OpenAlexW1998807018

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.